Syros(SYRS)

5.84 -0.41 -6.56%

今开:5.95昨收:6.25
最高:6.18 最低:5.44
涨停价:0.0跌停价:0.0
总市值:1.54490723E8

Syros的热门讨论

产业链观察2023-12-06 20:33

#药闻简讯# 2023 年 12 月 6 日,致力于推进血液恶性肿瘤一线治疗的新护理标准生物制药公司$Syros医药(SYRS)$ 今天宣布了来自其正在进行的 SELECT- 的强有力且令人鼓舞的初步数据 AML-1 2 期试验评估他米巴罗汀(一种口服选择性视黄酸受体 α (RARα) 激动剂)与维奈托克和阿扎胞苷联合治疗新诊断...查看全文

产业链观察2023-01-26 21:05

#药闻简讯# $Syros医药(SYRS)$ 获得用于治疗高风险骨髓增生异常综合征的Tamibarotene的快速通道认证查看全文

员工持股计划

Syros(SYRS)03-27 19:05

$Syros(SYRS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-078195  Act: 33  Size: 66 KB 网页链接查看全文

年度财报

Syros(SYRS)03-27 18:55

$Syros(SYRS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-036808  Act: 34  Size: 11 MB 网页链接查看全文

超过5%股东持股披露「修订」

Syros(SYRS)02-14 08:05

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034118  Act: 34  Size: 100 KB 网页链接查看全文

超过5%股东持股披露「修订」

Syros(SYRS)02-14 08:05

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034125  Act: 34  Size: 89 KB 网页链接查看全文

超过5%股东持股披露

Syros(SYRS)02-15 10:05

$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-24-008093  Act: 34  Size: 46 KB 网页链接查看全文

超过5%股东持股披露「修订」

Syros(SYRS)02-10 06:15

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-030282  Act: 34  Size: 159 KB 网页链接查看全文

超过5%股东持股披露「修订」

Syros(SYRS)02-14 09:25

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001214  Act: 34  Size: 183 KB 网页链接查看全文

超过5%股东持股披露「修订」

Syros(SYRS)02-07 20:15

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001134  Act: 34  Size: 101 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

Syros的新闻

骨髓增生性肿瘤治疗合作结束:因塞特(INCY.US)和Syros Pharmaceuticals(SYRS.US)宣布分道扬镳

智通财经APP获悉,因塞特(INCY.US)已经终止了与Syros Pharmaceuticals(SYRS.US)在骨髓增生性肿瘤治疗方面的发现和研究合作。终止协议将在8月9日起60天内生效。 2018年1月,因塞特和Syros Pharmaceuticals首次签署了一项合作协议。作为合... 网页链接

Syros的公告

员工持股计划

$Syros(SYRS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-078195  Act: 33  Size: 66 KB 网页链接

年度财报

$Syros(SYRS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-036808  Act: 34  Size: 11 MB 网页链接

超过5%股东持股披露

$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-24-008093  Act: 34  Size: 46 KB 网页链接

超过5%股东持股披露「修订」

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001214  Act: 34  Size: 183 KB 网页链接

超过5%股东持股披露「修订」

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034118  Act: 34  Size: 100 KB 网页链接

超过5%股东持股披露「修订」

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034125  Act: 34  Size: 89 KB 网页链接

超过5%股东持股披露「修订」

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-030282  Act: 34  Size: 159 KB 网页链接

超过5%股东持股披露「修订」

$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001134  Act: 34  Size: 101 KB 网页链接

当期报告

$Syros医药(SYRS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-24-003863  Act: 34  Size: 2 MB 网页链接

超过5%股东持股披露

$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-000007  Act: 34  Size: 69 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39